EUVIMEDEUVIMED entdecken
Crossref

Serum Zonulin as a Biomarker of Disease activity in Pediatric Inflammatory Bowel Disease (IBD)

Engy A. Boshra, Ayman E. Eskander, Ahmed S. El- Gayed, Mariam Saad Shawky, Radwa M Abdel Halim, Manar A. El Desouky

International Journal of Drug Delivery Technology · 24.04.2026 · 16 (19s)

DOI: 10.25258/ijddt.16.19s.9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 24.04.2026. Verfasst von Engy A. Boshra und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current information shows that impaired intestinal permeability has an essential role in pathogenesis of inflammatory bowel disease (IBD). Zonulin is 47-KD protein, has a central role in regulating intestinal permeability via modulating intercellular tight junctions between enterocytes, so it may act as a novel biomarker of illness activity. This research aimed to asses serum Zonulin in pediatric with IBD, as a potential biomarker in disease activity and remission. Methods: Eighty children: 50 Ulcerative colitis (UC) cases, 30 Crohn’s disease (CD) cases were examined for serum Zonulin which tested by ELISA test. Serum Zonulin level was evaluated in relation to age, gender, anthropometric data, IBD type, onset of disease, disease activity, laboratory investigations, Esophago-gastro-duodenoscopy and ileocolonoscopy and treatment modalities. Statistical tests have been applied for information analysis. Results: the median Zonulin in the studied group was 14.7ng/ml. Serum Zonulin level was statistically increased with higher disease severity compared to remission group: median for remission:10.8(10.2-14.6); mild exacerbation:16.9(11.7-29.7); moderate exacerbation:30.4(14.7-89.0) and severe exacerbation:64.3(45.8-225) ng/ml (P=0.002), strong correlation between serum Zonulin and Pediatric Ulcerative Colitis Activity Index (PUCAI), Pediatric Crohn’s Disease Activity Index (PCDAI) Score (p=

Zitieren

APA

Boshra, E. A., Eskander, A. E., Gayed, A. S. E., Shawky, M. S., Halim, R. M. A., & Desouky, M. A. E. (2026). Serum Zonulin as a Biomarker of Disease activity in Pediatric Inflammatory Bowel Disease (IBD). International Journal of Drug Delivery Technology, 16(19s). https://doi.org/10.25258/ijddt.16.19s.9

Vancouver

Boshra EA, Eskander AE, Gayed ASE, Shawky MS, Halim RMA, Desouky MAE. Serum Zonulin as a Biomarker of Disease activity in Pediatric Inflammatory Bowel Disease (IBD). International Journal of Drug Delivery Technology. 2026;16(19s). doi:10.25258/ijddt.16.19s.9

BibTeX
@article{Boshra2026,
  author = {Boshra, Engy A. and Eskander, Ayman E. and Gayed, Ahmed S. El- and Shawky, Mariam Saad and Halim, Radwa M Abdel and Desouky, Manar A. El},
  title = {Serum Zonulin as a Biomarker of Disease activity in Pediatric Inflammatory Bowel Disease (IBD)},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {19s},
  doi = {10.25258/ijddt.16.19s.9}
}
Kostenlos starten →